Latest 10-Q quarterly reports

Cardinal Infrastructure Group Inc. reported a significant increase in revenue and gross profit for the first quarter of 2026, driven by strategic acquisitions and organic growth.

Fuse Group Holding Inc. reports reduced revenue and operating expenses for Q1 2026, with a continued focus on consulting services and ongoing efforts to secure additional financing.

Journey Medical Corporation reported a 21% increase in total revenue for the first quarter of 2026, driven by strong performance in Emrosi, despite an overall net loss.

Adicet Bio, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing a net loss of $20.2 million and providing updates on its gamma delta T cell therapies.

MaxCyte reports a 7% year-over-year revenue decrease for Q1 2026, driven by lower core revenue, though SPL milestones and royalties saw a significant increase.

Lucid Diagnostics reports increased revenue in Q1 2026, but net loss widens due to higher operating expenses and changes in convertible note valuation.

Talphera, Inc. filed its Q1 2026 Form 10-Q, detailing ongoing development efforts for Niyad, continued net losses, and a need for additional capital, while also addressing a Nasdaq minimum bid price deficiency.

Fluent Inc. reported a 19% decrease in revenue for Q1 2026 to $44.9 million, with a net loss of $5.4 million, while highlighting a strategic shift towards Commerce Media Solutions.

CXApp Inc. reported a revenue decrease in Q1 2026 compared to the prior year, driven by a strategic shift away from lower-margin professional services towards its core SaaS offerings.

Republic Digital Acquisition Company reports Q1 2026 financial results, with net income driven by trust account investments and ongoing efforts to identify a business combination.

Verde Resources, Inc. announced its third quarter fiscal year 2026 financial results, highlighting a significant increase in revenue driven by initial sales of its Verde V24 product.

Dror Ortho-Design reports significant operating losses and a dwindling cash balance, raising substantial doubt about its ability to continue as a going concern, while also delaying its FDA submission for its novel orthodontic platform.

Range Capital Acquisition Corp. reports net income of $857,705 for Q1 2026, driven by trust account interest, while operational costs continue.

Nortech Systems Inc. reported a 12.7% increase in net sales for the first quarter of 2026, reaching $30.3 million, driven by growth in the Medical Imaging and Aerospace & Defense sectors, while also securing a new credit facility.

TurnOnGreen, Inc. reported a wider net loss for the first quarter of 2026, with revenues increasing 9% year-over-year, but operating expenses and interest expenses significantly rising.

Odyssey Marine Exploration, Inc. has filed an amendment to its Q1 2026 Form 10-Q to include inadvertently omitted exhibits and updated certifications.

GigCapital9 Corp. reports on its first quarter of 2026, detailing its financial position and ongoing efforts to identify and complete a business combination.

Seer, Inc. reported a 34% decrease in total revenue for the first quarter of 2026 compared to the prior year, driven by lower product and service sales.

New Peoples Bankshares, Inc. announced a significant increase in net income for the first quarter of 2026, driven by robust loan portfolio performance and improved net interest income.

Soulpower Acquisition Corporation reports on its Q1 2026 financial status, highlighting progress towards its business combination with SWB LLC and ongoing operational expenses.

Shoulder Innovations, Inc. announced its first quarter 2026 financial results, showcasing a significant 64.9% increase in net revenue to $16.7 million, driven by higher implant system sales and an expanded customer base.

TransAct Technologies Inc. saw a 10.4% increase in net sales for Q1 2026, driven by strong performance in the casino and gaming segment.

Genvor Incorporated files its Q2 2026 Form 10-Q, detailing increased R&D spending, significant stock-based compensation adjustments, and a new financing agreement.

Hawkeye Systems, Inc. filed its Form 10-Q for the quarter ended March 31, 2026, detailing a strategic pivot towards private equity and advisory services, alongside ongoing operational losses and a going concern warning.

Bonk, Inc. (formerly Safety Shot, Inc.) filed its Q1 2026 10-Q, detailing significant revenue growth driven by new acquisitions and a strategic pivot towards digital assets, while continuing to manage operational expenses and legal settlements.

Vivani Medical reports Q1 2026 results, detailing progress in its Biopharm Division, continued operational expenses, and strategic considerations for its Cortigent subsidiary.

Regis Corporation reports a decrease in total revenue for the third quarter of fiscal year 2026, driven by a decline in franchise rental income and fees, though company-owned salon revenue saw a slight increase.

vTv Therapeutics Inc. reported a significant revenue increase in Q1 2026 driven by an upfront payment from Newsoara Biopharma, while research and development expenses also rose.

Eledon Pharmaceuticals reported a wider net loss for Q1 2026, driven by increased manufacturing costs and R&D expenses, while cash reserves remain substantial.

Precigen Inc. announced its first-quarter 2026 financial results, showcasing a significant increase in product revenues driven by the commercial launch of Papzimeos.